Inactive Instrument

Alexza Pharmaceuticals, Inc. Stock Nasdaq

Stocks

End-of-day quote Nasdaq Other stock markets
- ^USD	-

16-03-28	Alexza Pharmaceuticals : Reports Fourth Quarter and Year End 2015 Financial Results	PU
16-03-15	Alexza Pharmaceuticals : to Report 2015 Year End Financial Results and Provide Company Update on Monday, March 28, 2016	PU
16-03-09	Alexza Pharmaceuticals : Receives Positive Nasdaq Listing Determination	PU
16-02-26	Alexza Pharmaceuticals : Confirms Grupo Ferrer Non-binding Letter of Intent	PU
16-02-24	Alexza Pharmaceuticals : Reacquires U.S. Commercial Rights for ADASUVE® (loxapine) inhalation powder	PU

15-12-22	Alexza Pharmaceuticals : Les valeurs à suivre sur les marchés américains
15-12-22	USA-Les valeurs à suivre à Wall Street

Manager	Title	Age	Since
Mario Rovirosa Escosura CEO	Chief Executive Officer	-	-
Stacy Palermini DFI	Director of Finance/CFO	-	2002-12-31
Wolfgang Schmidt PRN	Corporate Officer/Principal	-	2019-04-30

Director	Title	Age	Since
Jorge Ramentol Massana BRD	Director/Board Member	-	2016-06-20
Sergio Ferrer-Salat Serra di Migni BRD	Director/Board Member	-	2016-06-20
Joan Fanés Trillo BRD	Director/Board Member	-	2016-06-20

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
WUXI APPTEC CO., LTD.	+1.84%	-0.66%	+59.82%	+94.48%	54.88B
ARGENX SE	+0.29%	-5.78%	+57.16%	+130.24%	54.63B
INSMED INCORPORATED	-2.24%	+3.59%	+17.75%	+469.23%	25.06B
BIONTECH SE	-1.60%	-6.21%	-18.96%	-16.06%	23.14B
WUXI BIOLOGICS (CAYMAN) INC.	-1.69%	-1.27%	+39.51%	-8.30%	19.87B
GENMAB A/S	+0.27%	+2.49%	+36.52%	-27.60%	17.55B
PHARMAESSENTIA CORPORATION	-6.84%	+2.18%	+195.12%	+364.56%	16.5B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-2.42%	-3.72%	+47.02%	+635.77%	15.75B
EXELIXIS, INC.	-1.05%	+1.16%	+25.95%	+191.69%	14.2B
Average	-1.25%	-0.28%	+51.10%	+203.78%	26.84B
Weighted average by Cap.	-0.50%	-1.45%	+50.37%	+172.98%

Employees

Sector